A range of inflammation-based indices—such as the neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio, and CRP—have been linked to clinical prognosis in HCC.25 This evidence concerns the gene CRP and hepatocellular carcinoma.